STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Currency in USD	2026
Operating Income	1.10 Billion
Income Before Tax	1.05 Billion
Income Tax Expense	262.20 Million
Net Income	782.30 Million
Eps	7.97
Epsdiluted	7.93
Weighted Average Shs Out	98.20 Million
Weighted Average Shs Out Dil	98.70 Million
Research And Development Expenses	112.90 Million
Selling General And Administrative Expenses	1.41 Billion
Depreciation And Amortization	486.50 Million
Interest Expense	60.70 Million
Interest Income	9.80 Million
Net Interest Income	-50.9 Million
Premiums Earned	N/A
Policyholder Benefits	N/A
Gross Profit	2.63 Billion
Ebitda	1.59 Billion
Source	edgar
Ebit	1.11 Billion

STERIS plc Annual Reports (10-K)